Shivani Reddy

Dr. Shivani Reddy

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KAKarla Maria Asturias
Karla Maria Asturias
SLSarah Li
Sarah Li
SRShivani Reddy
Shivani Reddy
PJPeter M Jessel
Peter M Jessel
NNNorth J. Noelck
North J. Noelck
DLDai-Trang Le
Dai-Trang Le
Background/Objective: Pacing-induced cardiomyopathy (PICM) is a common complication of right ventricular (RV) pacing, affecting 6–25% of patients with frequent RV pacing, due to electrical and mechanical dyssynchrony. Certain clinical and electrocardiographic risk factors have been identified, including high RV-pacing burden and longer paced QRS, but their ability to predict the development PICM remains limited. Additionally, other forms of PICM have been described, including heart failure with preserved ejection fraction and RV failure. The goal of this narrative review is to summarize the current evidence utilizing noninvasive imaging to identify patients predisposed to a high risk of PICM. Methods: Using a literature search in the PubMed, Scopus, Google Scholar, and the Cochrane databases from 2000 to 2025, which included but was not limited to the keywords right ventricular pacing, pacemaker-related cardiomyopathy, pacemaker-induced cardiomyopathy, biventricular pacing, conduction system pacing, His bundle pacing, left bundle pacing, echocardiography, computed tomography imaging, and cardiac magnetic resonance imaging, we reviewed randomized control trials, observational retrospective and prospective cohort studies, societal guidelines, and systematic review articles. Conclusions: Essential in the diagnosis of PICM, cardiac imaging can identify patients at risk, even before left ventricular (LV) dysfunction or symptoms develop. Pre- and early post-implantation 2- and 3-dimensional echocardiography with global longitudinal strain provides sensitive parameters for the potential development of PICM. Relative indices of contractile asymmetry have been described. Cardiac magnetic resonance imaging offers an accurate assessment of cardiac volumes and LV synchrony and can also quantify myocardial fibrosis, a significant predictor of PICM. Performing pre-device implantation imaging may help predict subsequent heart failure development and potentially can guide pacing modality selection that can mitigate this risk. Thus, an imaging-guided framework will advance the management of PICM.

18 August 2021 in Journal of Cardiology Cases
Verified
Journal Article
Closed access
NLNeiberg de Alcantara Lima
Neiberg de Alcantara Lima
ANAne Karoline Medina Neri
Ane Karoline Medina Neri
SVSara da Silva Veras
Sara da Silva Veras
IGIsabela Thomaz Takakura Guedes
Isabela Thomaz Takakura Guedes
MAMariana Silton Pinheiro de Araujo
Mariana Silton Pinheiro de Araujo
NHNicholas Helmstetter
Nicholas Helmstetter

5 August 2026 in US Cardiology Review
Verified
Journal Article
Open access
PDF file
RSRebecca S Steinberg
Rebecca S Steinberg
RTRitika Tuli
Ritika Tuli
SRShivani Reddy
Shivani Reddy
RTRafael Toro-Manotas
Rafael Toro-Manotas
NMNatalie Marrero
Natalie Marrero
MMManu Murali Mysore
Manu Murali Mysore
Recent data suggest that sodium–glucose cotransporter 2 inhibitors have cardioprotective benefits. This effect may extend towards cardioprotection in cancer therapy-related cardiac dysfunction, with proposed mechanisms extending beyond glycemic control to include anti-inflammatory effects, oxidative stress reduction, and metabolic reprogramming. This review synthesizes potential mechanisms, observational data, and emerging trial evidence to support sodium–glucose cotransporter 2 inhibitors as a primary prevention strategy for cancer therapy-related cardiac dysfunction, particularly in anthracycline-exposed populations.